Gene therapy for deafness: 5-Year safety watch begins
Disease control
ENROLLING_BY_INVITATION
This study follows 30 people for up to five years after they received an experimental gene therapy for hearing loss. The goal is to monitor for any long-term safety issues and see if the treatment's benefits last. Participants had a specific type of genetic hearing loss and recei…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC